Sichenzia Ross Ference LLP Represents Boustead Securities, LLC as Underwriter to MAINZ BIOMED B.V. in $11.5 Million U.S. Initial Public Offering

Press Release – New York, NY – November 11, 2021 – Sichenzia Ross Ference LLP congratulates MAINZ BIOMED B.V. (the “Company”) (NASDAQ: MYNZ ), a molecular genetics diagnostic company specializing in the early detection of cancer, on the final closing of its initial public offering on November 9, 2021. The Company raised $11.5 million in gross proceeds, before deducting underwriting discounts, commissions and other offering expenses, by issuing 2,300,000 common shares at a public offering price of $5.00 per share. The ordinary shares commenced trading on the Nasdaq Capital Market on November 5, 2021 under the ticker symbol “MYNZ”.

Boustead Securities, LLC acted as the sole underwriter for the offering and the Firm acted as legal counsel to the underwriter. The Sichenzia Ross Ference LLP team was led by Senior Partner, Benjamin Tan.

Author
Recent Posts

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a full service law firm with a nationally recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry. In addition to handling routine to complex commercial matters, SRF’s renowned litigation department specializes in defending companies and individuals against all types of securities cases, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations. The litigation team has also brought defamation lawsuits against companies and individuals related to market manipulation. Additionally, it represents individuals and companies in investigations by the Securities and Exchange Commission (SEC) and other regulatory bodies. The litigation team has a robust practice representing brokers and broker-dealers in arbitrations before the Financial Industry Regulatory Authority (FINRA). These arbitrations typically involve claims of unsuitability, churning, unauthorized trading and other allegations of broker misconduct. Finally, SRF has a burgeoning expungement practice, where it represents brokers seeking to have negative and harmful customer complaints removed from their industry records. The firm complements its core practice areas with an established commercial real estate and trusts and estates practice.

Visit SRF's LinkedIn page

Latest posts by Sichenzia Ross Ference LLP (see all)

Sichenzia Ross Ference LLP Represents ThinkEquity LLC in $6.87 Million Public Offering of Common Stock of Twin Vee PowerCats Co. - October 4, 2022
Sichenzia Ross Ference LLP Represents Laidlaw & Company (UK) Ltd. in $5.75 Million Public Offering and Nasdaq Uplisting of Silo Pharma, Inc. - October 1, 2022
Mid-Level Corporate Associate - September 29, 2022

Sichenzia Ross Ference LLP Represents Boustead Securities, LLC as Underwriter to MAINZ BIOMED B.V. in $11.5 Million U.S. Initial Public Offering

Related Posts